Cargando…
Costs and utilization of treatment in patients with hemophilia
BACKGROUND: Although hemophilia has a potentially high economic impact, there are no published estimates of healthcare costs for this disease in Portugal. The aim of this study was to evaluate costs of treatment and hospital utilization among patients with hemophilia A and B, with and without inhibi...
Autores principales: | Rocha, Patrícia, Carvalho, Manuela, Lopes, Manuela, Araújo, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624363/ https://www.ncbi.nlm.nih.gov/pubmed/26502954 http://dx.doi.org/10.1186/s12913-015-1134-3 |
Ejemplares similares
-
Hemophilia Burden of Disease: A Systematic Review of the Cost-Utility Literature for Hemophilia
por: Thorat, Teja, et al.
Publicado: (2018) -
Cost–utility analysis of prophylaxis versus treatment on demand in severe hemophilia A
por: Colombo, Giorgio L, et al.
Publicado: (2011) -
Medical Costs and Resource Utilization for Hemophilia Patients With and Without HIV or HCV Infection
por: Tencer, Thomas, et al.
Publicado: (2007) -
Sociodemographic, Clinical, and Psychosocial Characteristics of People with Hemophilia in Portugal: Findings from the First National Survey
por: Pinto, Patrícia Ribeiro, et al.
Publicado: (2018) -
Resource utilization and treatment costs of patients with severe hemophilia A: Real‐world data from the ATHNdataset
por: Recht, Michael, et al.
Publicado: (2022)